Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine‐Type Drugs
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The abuse of illicit stimulants is a worldwide crisis, yet few medicines are available for treating stimulant addiction. We have advocated the idea of “agonist therapy” for cocaine dependence. This strategy involves administration of stimulant‐like medications (e.g., monoamine releasers) to alleviate cocaine withdrawal symptoms and prevent relapse. A chief limitation of this strategy is that many candidate medicines possess high abuse liability due to activation of mesolimbic dopamine (DA) neurons in reward pathways. Evidence suggests that serotonin (5‐HT) neurons can provide an inhibitory influence over mesolimbic DA neurons. Thus, it might be predicted that the balance between DA and 5‐HT transmission is a critical variable when developing medications with reduced stimulant side effects. In this article, we review recent studies from our laboratory that examined neurochemical and behavioral effects of a series of monoamine releasers which displayed different potencies at DA and 5‐HT transporters. The data show that increasing 5‐HT release can attenuate stimulant effects mediated by DA release, such as motor stimulation and drug self‐administration. Our findings support the work of others and indicate that elevated synaptic 5‐HT can dampen certain behavioral effects of DA‐releasing agents. Moreover, the relationship between DA and 5‐HT releasing potency is an important determinant in developing new agonist medications with reduced stimulant properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Opponent interactions between serotonin and dopamine
Daw, N. D., Kakade, S., & Dayan, P. (2002) · Neural Networks · doi:10.1016/s0893-6080(02)00052-7 · Cited by 844
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607
Nicotine Medications for Smoking Cessation
Henningfield, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331807 · Cited by 352
Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial
Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00010 · Cited by 243
Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185
Cited by
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F., & Yoshitake, T. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01499.x · Cited by 312
Mimiaga, M. J., Reisner, S. L., Pantalone, D. W., O'Cleirigh, C., Mayer, K. H., & Safren, S. A. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0216 · Cited by 84
Tan, H., Young, L. T., Shao, L., Che, Y., Honer, W. G., & Wang, J.-F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001416 · Cited by 40
Hutson, P. H., Tarazi, F. I., Madhoo, M., Slawecki, C., & Patkar, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.005 · Cited by 31
Metadata
- Authors
- ROTHMAN, R. B., & BAUMANN, M. H.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2006-08
- Volume
- 1074
- Issue
- 1
- Pages
- 245-260
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2108827491
- Cited by
- 123
- References
- 7
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine‐Type Drugs. https://app.cochat.ai/papers/10.1196/annals.1369.064
- The paper
- ROTHMAN, R. B., & BAUMANN, M. H. (2006). Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine‐Type Drugs. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1369.064
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.